Background: New technologies and therapies allow the possibility of a single-visit test and
treat model for hepatitis C virus (HCV), addressing some of the barriers to care faced by …

Summary Background Although treatment for Hepatitis C Virus (HCV) is effective, individuals
face access barriers. The utility of mobile health clinics (MHC), effective mechanisms for …

Objectives: The care cascade, a method for tracking population-level progression from
diagnosis to cure, is an important tool in addressing and monitoring the hepatitis C virus …

Point-of-care hepatitis C virus (HCV) RNA testing is advantageous, enabling diagnosis of
active infection in a single visit. This study evaluated the sensitivity and specificity of the …

Introduction Injecting drug use is the primary driver of hepatitis C virus (HCV) infection in
Europe. Despite the need for more engagement with care, people who inject drugs (PWID) …

Background People who inject drugs have high rates of hepatitis C (HCV) and yet many
remain undiagnosed and untreated. HCV treatment guidelines and elimination strategies …

An estimated 3.2 million persons in the United States have chronic infection with hepatitis C
virus (HCV)(1). Most new HCV transmissions occur among persons who inject drugs (2) …

Abstract In 2016, the World Health Organization introduced global targets for the care and
management of hepatitis C virus (HCV) infection to eliminate hepatitis C as a public health …

Background & Aims Affordable point-of-care tests for hepatitis C (HCV) viraemia are needed
to improve access to treatment in low-and middle-income countries. Our aims were to …

Background People who inject drugs (PWID) are at high risk for hepatitis C virus (HCV)
infection and its complications in many countries, including Iran. This pilot study aimed to …